Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Good-Bye Licensing Deal, Hello Partner!
Biotechs get what they want using strategic partnerships and alliances
Email: Susan Warner - swarner@the-scientist.com The Scientist 2005, 19(11):36
|
||||
|
|
||||
|
Medarex, a Princeton, NJ, biotech focused on monoclonal antibodies, has done dozens of straight licensing deals in the past, including an agreement signed last year with Pfizer to produce 50 antibody products over 10 years. Pfizer paid $80 million up front and could pay Medarex more than $400 million if all the products win regulatory approval.
|
|
|||||||||
|
|||||||||
|
